Inhibrx Biosciences (NASDAQ: INBX)
$34.31
(1.0%)
$0.33
Price as of October 2, 2025, 2:32 p.m. ET
Inhibrx Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Inhibrx Biosciences Company Info
Inhibrx Biosciences, Inc. operates as an American clinical-stage biotechnology company for biologic therapeutic candidates. The private company is based in DE.
News & Analysis
Featured Article
Inhibrx Biosciences Beats Earnings
Motley Fool Markets Team | Aug 13, 2025
Featured Article
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Jack Caporal | May 15, 2024
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.